BioSpace News Archive

Business

Strand Therapeutics Awarded Phase I NIH SBIR Contract to Develop mRNA-based CAR-T Immunotherapy for Non-Hodgkin’s Lymphoma

Strand Therapeutics today announced that the company was awarded a Phase I Small Business Innovation Research (SBIR) contract from the National Cancer Institute (NCI)

November 9, 2021
·
3 min read
Biotech Bay

Iovance Biotherapeutics Announces Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Cell Therapy in Multiple Solid Tumors at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), today announced the publication of abstracts with clinical data for Iovance tumor-infiltrating lymphocyte (TIL) therapy in combination with pembrolizumab in patients with advanced cancers and for Iovance TIL cell therapy in relapsed, refractory lung cancer.

November 9, 2021
·
10 min read
Business

Sensei Biotherapeutics Reports Third Quarter 2021 Results and Recent Business Highlights

Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), today reported financial results for the third quarter ended September 30, 2021 and provided recent corporate updates.

November 9, 2021
·
11 min read
BioForest

Seagen to Highlight Two Novel Antibody-Drug Conjugates (ADCs) at the SITC 36th Annual Meeting

Seagen Inc. (Nasdaq:SGEN), today announced the presentation of two new vedotin-based antibody-drug conjugate (ADC) programs at the Society for Immunotherapy of Cancer (SITC) 36th Anniversary Annual Meeting, taking place in Washington, D.C. and virtually, November 10-14, 2021.

November 9, 2021
·
4 min read
Deals

Sanofi completes acquisition of Kadmon

Paris– November9, 2021 - Sanofi announced the completion of its acquisition of Kadmon Holdings, Inc.

November 9, 2021
·
5 min read
Biotech Beach

Fate Therapeutics Announces Abstract Highlighting FT538 and FT573 Programs Selected for Presentation at SITC 2021 Annual Meeting Press Conference

Fate Therapeutics, Inc. (NASDAQ: FATE), today announced that the Society for Immunotherapy of Cancer (SITC) Communications Committee selected an abstract featuring preclinical data from the Company’s FT538 and FT573 programs for showcase at the SITC 2021 Annual Meeting Press Conference.

November 9, 2021
·
8 min read
Business

Noema Pharma expands its Board of Directors with the appointments of Catherine Moukheibir and Ilise Lombardo

Noema Pharma, a Swiss-based clinical stage company targeting orphan central nervous system diseases, announces the appointment of Catherine Moukheibir and Ilise Lombardo as independent members of the company’s Board of Directors.

November 9, 2021
·
4 min read
Biotech Beach

Bioniz Therapeutics to Present at Evercore ISI 4th Annual HealthCONx Conference

Bioniz Therapeutics, Inc., today announced that management will participate in a fireside chat at the upcoming Evercore ISI 4th Annual HealthCONx Conference on Wednesday, December 1, 2021, at 1:00pm Eastern Time.

November 9, 2021
·
1 min read
BioCapital

GlycoMimetics to Present at Two Upcoming Healthcare Investor Conferences - Nov 09, 2021

GlycoMimetics, Inc., announces that Chief Executive Officer Harout Semerjian will present an overview of the company at the upcoming Stifel 2021 Virtual Healthcare Conference on Monday, November 15 and the Jefferies London Healthcare Conference on Wednesday, November 17.

November 9, 2021
·
1 min read
CATHETRIX to Reveal New Catheter Stabilizer at MEDICA 2021

CATHETRIX, an innovative developer of urinary smart catheter fixations, will present its new catheter stabilizer for prevention of UTIs and accidental Foley catheter extractions at MEDICA 2021, which will take place November 15–18 in Dusseldorf, Germany.

November 9, 2021
·
2 min read